TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 130 resultados LastUpdate Última actualización 22/09/2021 [23:20:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 6 nextPage   por página


INTEGRATED USER-DEFINED INPUT INTO A CLOSED-LOOP GLUCOSE CONTROL SYSTEM

NºPublicación: WO2021183611A1 16/09/2021

Solicitante:

UNIV BOSTON [US]
BETA BIONICS INC [US]

US_2021283332_A1

Resumen de: WO2021183611A1

A controller in a system for automatic control of blood glucose level of a subject is operative to generate an insulin dose control signal for controlling insulin delivery by a delivery device, based on time-varying glucose levels of the subject as represented by an actual glucose level signal over time. The controller operates at a regular frequency to generate the insulin dose control signal to regulate the glucose levels in the subject and employs a control algorithm that functions in conjunction with and accounting for user-determined doses, such as meal doses, whose values are entered into the controller and delivered on command of a user.

traducir

Diabetic Nephropathy Recognition System Based on Fundus Image

NºPublicación: AU2021104374A4 16/09/2021

Solicitante:

CAPITAL MEDICAL UNIV

Resumen de: AU2021104374A4

The invention discloses a diabetic nephropathy recognition system based on fundus images, which comprises an image data acquisition module, a data processing module and a diabetic nephropathy recognition module which are sequentially connected; The diabetic nephropathy identification module is also connected with a data storage device; The image data acquisition module is used for acquiring color fundus images of diabetic patients; The data processing module is used for preprocessing the color fundus image acquired by the image data acquisition module and constructing the fundus image data set; The diabetic nephropathy recognition module constructs a diabetic nephropathy recognition model based on ResNet convolutional neural network, and trains the diabetic nephropathy recognition model through fundus image data set, and the trained diabetic nephropathy recognition model is used for diabetic nephropathy recognition; The data storage device is used for storing the colour fundus image data and the recognition result of diabetic nephropathy. The method can quickly and accurately identify diabetic nephropathy without personal experience of doctors. Diabetic nephropathy recognition module Model construction module Image data Data M . Data Model trainig acquisition - processmig module storage module module device Diabetic Image nephropathy impue recognition module module Figure 1 Funds ResNet5O+ image Convolutional Layer 0 Figure 2

traducir

ANALYTE SENSOR

NºPublicación: US2021282682A1 16/09/2021

Solicitante:

DEXCOM INC [US]

US_2021259587_A1

Resumen de: US2021282682A1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

traducir

INTEGRATED USER-DEFINED INPUT INTO A CLOSED-LOOP GLUCOSE CONTROL SYSTEM

NºPublicación: US2021283332A1 16/09/2021

Solicitante:

UNIV BOSTON [US]
BETA BIONICS INC [US]

WO_2021183611_A1

Resumen de: US2021283332A1

A controller in a system for automatic control of blood glucose level of a subject is operative to generate an insulin dose control signal for controlling insulin delivery by a delivery device, based on time-varying glucose levels of the subject as represented by an actual glucose level signal over time. The controller operates at a regular frequency to generate the insulin dose control signal to regulate the glucose levels in the subject and employs a control algorithm that functions in conjunction with and accounting for user-determined doses, such as meal doses, whose values are entered into the controller and delivered on command of a user.

traducir

WEARABLE WIRELESS NON-INVASIVE BLOOD GLUCOSE MEASUREMENT SYSTEM

NºPublicación: WO2021183836A1 16/09/2021

Solicitante:

PETCAVICH ROBERT JOHN [US]

US_2021282673_A1

Resumen de: WO2021183836A1

The present invention discloses a wearable, wireless, non-invasive blood glucose measurement system comprising an infrared LED-enabled wireless ring interfaced with machine learning software wherein the ring outputs data from the wearer used to determine the blood glucose concentrations of the wearer in real time. The blood glucose data analytics can be subsequently sent to, and displayed on, a smart mobile device, such as an iPhone®, or distributed over a cloud network.

traducir

METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERY

NºPublicación: US2021282677A1 16/09/2021

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2021038132_A1

Resumen de: US2021282677A1

An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT APPARATUS

NºPublicación: US2021282675A1 16/09/2021

Solicitante:

I SENS INC [KR]

AU_2019315233_A1

Resumen de: US2021282675A1

The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

traducir

WEARABLE WIRELESS NON-INVASIVE BLOOD GLUCOSE MEASUREMENT SYSTEM

NºPublicación: US2021282673A1 16/09/2021

Solicitante:

PETCAVICH ROBERT JOHN [US]

Resumen de: US2021282673A1

The present invention discloses a wearable, wireless, non-invasive blood glucose measurement system comprising an infrared LED-enabled wireless ring interfaced with machine learning software wherein the ring outputs data from the wearer used to determine the blood glucose concentrations of the wearer in real time. The blood glucose data analytics can be subsequently sent to, and displayed on, a smart mobile device, such as an iPhone®, or distributed over a cloud network.

traducir

MULTISPOT MONITORING FOR USE IN OPTICAL COHERENCE TOMOGRAPHY

NºPublicación: US2021282679A1 16/09/2021

Solicitante:

MASIMO CORP [US]

US_2019357823_A1

Resumen de: US2021282679A1

Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

traducir

CONTINUOUS BLOOD GLUCOSE MONITORING DEVICE

NºPublicación: WO2021177686A1 10/09/2021

Solicitante:

I SENS INC [KR]

Resumen de: WO2021177686A1

The present invention relates to a continuous blood glucose monitoring device, and provides a continuous blood glucose monitoring device, which has an incision area formed by means of a guide needle, in a state in which a body-attaching unit is insertively attached to a body, so as not to encompass at least a part of a region of a sensing area formed in a sensor member, so that the incision part is not formed near the sensing area, and thus the present invention can prevent a decrease in a blood glucose monitoring value that occurs because of the incision part so as to detect an accurate blood glucose monitoring value from an initial operation stage, and adjusts an insertion depth of the guide needle through an applicator when the body-attaching unit is insertively attached to the human body, so as to adjust the separation distance between the incision part and the sensing area by means of the guide needle, thereby improving blood glucose monitoring accuracy.

traducir

BONE IMPLANT

NºPublicación: WO2021176449A1 10/09/2021

Solicitante:

KARMON BENNY [IL]

Resumen de: WO2021176449A1

Devices and methods to perform measurements of body analytes, like glucose, using a bone implant and/or a dental implant and/or a jawbone implant and an analyte measuring component. The dental implant can have a protruding component that protrudes to the oral cavity for many years and therefore enable long-term handling of the analyte measuring component and long-term monitoring of the analyte. The new device enables for example, to replace at least part of the analyte measuring component, to replace materials of the analyte measuring component and the energy source of the device without surgery.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT DEVICE

NºPublicación: WO2021177687A1 10/09/2021

Solicitante:

I SENS INC [KR]

Resumen de: WO2021177687A1

The present invention relates to a continuous blood glucose measurement device configured to prevent, in a state where a body attachment unit is inserted in and attached to a human body, an incision portion made by a guide needle from being formed to surround at least a part of a sensing area formed at a sensing member, whereby an incision portion is not formed around the sensing area so as to prevent the incision portion from causing a drop in a blood glucose measurement value and thus enable detection of an accurate blood glucose measurement value from the early stage of operation. Further, the guide needle has a shape not surrounding at least a part of the sensing area, so as to prevent, even without an additional device, the guide needle from forming an incision portion around the sensing area in a human body and thus enhance, by a simple structure, the accuracy of blood glucose measurement.

traducir

DEVICE FOR CONTROLLING INJECTION OF MEDICINAL FLUID

NºPublicación: WO2021177747A1 10/09/2021

Solicitante:

EOFLOW CO LTD [KR]

Resumen de: WO2021177747A1

Disclosed in one embodiment of the present invention is a device for controlling the injection of a medicinal fluid, comprising: a blood sugar measurement part for sequentially measuring the blood sugar of an injectee at least a plurality of times; a first medicinal fluid injection part for injecting the injectee with a first medicinal fluid containing a substance for controlling a decrease in blood sugar of the injectee; and a first medicinal fluid injection part for injecting the injectee with a second medicinal fluid which contains a substance for controlling an increase in the blood sugar of the injectee and which contains a substance that is different from the first medicinal fluid.

traducir

OPTIMIZING ANALYTE SENSOR CALIBRATION

NºPublicación: US2021275065A1 09/09/2021

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2021059580_A1

Resumen de: US2021275065A1

Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT APPARATUS

NºPublicación: US2021275066A1 09/09/2021

Solicitante:

I SENS INC [KR]

AU_2019314012_A1

Resumen de: US2021275066A1

The present disclosure relates to a continuous glucose monitoring device, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work for a user in attaching the body attachment unit to a body, and allowing attachment of the body attachment unit to the body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, the continuous glucose monitoring device is activated by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and the continuous glucose monitoring device can be activated in a stabilized state, and thereby can monitor blood glucose more accurately.

traducir

METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2021275785A1 09/09/2021

Solicitante:

NEUROTRONIC INC [US]

US_2021275784_A1

Resumen de: US2021275785A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, nonalcoholic fatty liver disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2021275787A1 09/09/2021

Solicitante:

NEUROTRONIC INC [US]

US_2021275784_A1

Resumen de: US2021275787A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, nonalcoholic fatty liver disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

Behavioural Modification by Virtual Coaching Device

NºPublicación: AU2021104306A4 09/09/2021

Solicitante:

MEDICAL AI PTY LTD
HEALEA PTY LTD

Resumen de: AU2021104306A4

Abstract Chronic diseases like diabetes mellitus and cardiovascular disease account for a high degree of morbidity and mortality contributing to the global burden of diseases. Common to all these conditions are pre-existing risk factors, whether it be modifiable or absolute or both. Evidence indicates frequent communication between physician and the patients coupled with monitoring of patient-derived data like blood sugar levels, physical activity levels, dietary intake and medication use, limit the progression of disease. Our patent application is for behavioural and risk modification undertaken by virtual coaching delivered by a wearable device (1) with display and notification features (2) supported by a digital ecosystem (3, 4) integrating patient data with an application (5) embedded in a clinical information system. Drawings Patient Data from Wearable Device collected Data analysed with Edge Al Data Relayed to Mobile Application and Cloud Server Mobile Application presents Dashboard and Detailed Analysis Mobile Application relays Data to Cloud Server Cloud Server relays Data to Clinical Practice Information System Figure 1

traducir

METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2021275784A1 09/09/2021

Solicitante:

NEUROTRONIC INC [US]

US_2021275786_A1

Resumen de: US2021275784A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, nonalcoholic fatty liver disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

HUMAN GAS SENSING GLUCOSE MONITORING AND KETONE FLUCTUATION DETECTION DEVICE

NºPublicación: US2021275061A1 09/09/2021

Solicitante:

BETTER LIFE TECH GROUP INC [US]

US_10959651_B1

Resumen de: US2021275061A1

Devices and methods of detecting gas and volatile organic compounds from skin are disclosed. One system for detecting emissions through skin includes a sensing device having a housing having a top portion and a bottom portion, the bottom portion having a concave-shaped bottom surface creating a cavity region, the at least one light source arranged to emit a spectral range of wavelengths of light into the cavity region, and at least one sensor disposed to receive light emitted by the at least one sensor after the light propagates through at least a portion of the cavity region, the at least one sensor configured to generate a signal based on the received light. The sensing device may also include a communication module configured wirelessly transmit the spectral information to a mobile device for determining a characteristic, for example, a blood glucose level.

traducir

INSULIN PUMP COMPATIBLE UNDERGARMENTS

NºPublicación: US2021274855A1 09/09/2021

Solicitante:

HERMSEN LAUREN ANNE [US]

Resumen de: US2021274855A1

An insulin pump compatible undergarment has a pocket to contain an insulin pump and an access port to accommodate medical tubing. The pocket has an opening overlapped with a pocket edge. A method of wearing an insulin pump includes donning the undergarment; inserting an insulin pump into the overlapped pocket; feeding medical tubing through the access port; coupling the medical tubing with the insulin pump; and coupling the medical tubing with a cannula inserted at an infusion site.

traducir

METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2021275786A1 09/09/2021

Solicitante:

NEUROTRONIC INC [US]

US_2021275784_A1

Resumen de: US2021275786A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, nonalcoholic fatty liver disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

INSULIN-DOSAGE DETECTION DEVICE

NºPublicación: EP3875132A1 08/09/2021

Solicitante:

QUANTA COMP INC [TW]

US_2021268199_A1

Resumen de: EP3875132A1

An insulin-dosage detection device is arranged on a rotation member of an insulin injection pen having an injection button. The rotation variation of the rotation member corresponds to the injection dosage of the insulin injection pen. The insulin-dosage detection device has a circuit, a detection button, and a processor. The circuit, arranged on the rotation member of the insulin injection pen, is configured to output electronic signals in response to rotation of the rotation member. The detection button is connected to the injection button. The rotation member of the insulin injection pen rotates in response to the detection button and the injection button being pressed. The circuit rotates along with the rotation member. The processor, coupled to the circuit, calculates the rotation variation of the rotation member according to a first electronic signal and a second electronic signal respectively output from the circuit before and after the rotation of the circuit.

traducir

METHOD FOR DIAGNOSIS OF AUTONOMIC POLYNEUROPATHY IN PATIENTS WITH DIABETIC FOOT SYNDROME

NºPublicación: RU2754949C1 08/09/2021

Solicitante:

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA SAMARSKIJ G [RU]

Resumen de: RU2754949C1

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to neurology, endocrinology, and can be used in the diagnosis of autonomic polyneuropathy in patients with diabetic foot syndrome. In a patient at rest, in a sitting position, the initial temperature of the foot dorsum skin is measured, then a cold test is performed. After performing the test, re-measure the temperature of the foot dorsum skin and then repeat the temperature measurement every 5 minutes six times. The data is recorded on a graph. Then a temperature curve is built and the presence or absence of vegetative diabetic polyneuropathy is diagnosed in the patient.EFFECT: invention allows reasonably carrying out preventive measures in patients with asymptomatic clinical picture and timely prescribing them adequate therapy due to the combination of techniques of the claimed invention.1 cl, 2 dwg, 2 ex

traducir

DEVICES, METHODS, AND SYSTEMS FOR THE TREATMENT AND/OR MONITORING OF DAMAGED TISSUE

Nº publicación: US2021268267A1 02/09/2021

Solicitante:

ADLORE INC [US]

AU_2019217431_A1

Resumen de: US2021268267A1

Disclosed are methods, devices, and systems for treatment of an abnormal wound healing response. The methods, devices, and systems can be used to treat solid ulcerated tissue, such as diabetic foot ulcers (DFUs), arthritic tissue, muscle soreness, joint pain, varicose veins, obesity, and peripheral artery disease. Additionally, the methods, devices, and systems can promote the healing of xenograft, allograft, autograft, or engineered tissue following reconstruction surgery. The methods, devices, and systems include the ability to determine an optimal set of pulse parameters that are specific to wound healing. In embodiments, the methods, devices, and systems include components for guiding the user on electrode placement based on anatomical or electrical measurements, delivering a custom series of electric pulses, applying heat, and using feedback from physiologic measurements to control the device.

traducir

Página1 de 6 nextPage por página

punteroimgVolver